Profund Advisors’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $385K | Sell |
8,831
-3,718
| -30% | -$162K | 0.01% | 558 |
|
|
2025
Q1 | $343K | Buy |
12,549
+1,052
| +9% | +$28.8K | 0.01% | 616 |
|
|
2024
Q4 | $463K | Sell |
11,497
-1,814
| -14% | -$73K | 0.02% | 562 |
|
|
2024
Q3 | $630K | Sell |
13,311
-3,700
| -22% | -$175K | 0.02% | 446 |
|
|
2024
Q2 | $508K | Sell |
17,011
-15,814
| -48% | -$472K | 0.02% | 489 |
|
|
2024
Q1 | $1.32M | Buy |
32,825
+12,938
| +65% | +$520K | 0.05% | 279 |
|
|
2023
Q4 | $506K | Sell |
19,887
-5,567
| -22% | -$142K | 0.02% | 515 |
|
|
2023
Q3 | $354K | Sell |
25,454
-13,375
| -34% | -$186K | 0.02% | 584 |
|
|
2023
Q2 | $893K | Buy |
38,829
+91
| +0.2% | +$2.09K | 0.05% | 342 |
|
|
2023
Q1 | $1.15M | Buy |
+38,738
| New | +$1.15M | 0.07% | 269 |
|